InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the detailed record of transactions filed by McNeill Lori. Officer active across 1 company, notably Sonnet BioTherapeutics Holdings, Inc.. Aggregated, 4 filings have been published. Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
McNeill Lori is a director of Sonnet BioTherapeutics Holdings, Inc. She has 4 filings in total in the available data, and the 4 sampled filings cover the period from 2022-12-22 to 2025-12-03. The modal transaction nature is Attribution, and the cumulative buy and sell amounts shown for these recent filings are EUR 0 each.